ABPN NDD
ABPN Neurodevelopmental Disabilities
Neuromuscular IemEnglish
Exam overviewPractice session
A newborn is identified with spinal muscular atrophy type I via newborn screening with 2 SMN2 copies. Which disease-modifying gene therapy is a one-time intravenous infusion FDA-approved for SMA in patients under 2 years of age?
Loading your practice session…